At the heart of Smilow Cancer Hospital and Yale Cancer Center, our commitment to safety, compassionate care, and research excellence will always remain.
Patient and Cancer Information
Yale Cancer Center is Connecticut's only cancer center designated as a Comprehensive Cancer Center by the National Cancer Institute- and one of only 57 in the nation. The significance of this designation has profound implications for those who choose Smilow Cancer Hospital as the place where they will be cared for and receive treatment for their cancer. National Cancer Institute cancer centers are national leaders in cancer research, prevention, detection, and treatment. This provides patients at Smilow Cancer Hospital with novel treatment options and expert care.
The delivery of cancer care is becoming ever more complex, involving multiple disciplines for the diagnosis and treatment of patients. In response, Smilow Cancer Hospital and Yale Cancer Center have developed 13 multidisciplinary clinical centers to care for patients diagnosed with cancer. The clinical centers allow physicians and specialists at Smilow Cancer Hospital to focus their expertise on specific types of cancers enabling them to provide superior care to our patients through a patient-friendly system of care led by a nurse coordinator. Our nationally recognized physicians provide unparalleled cancer expertise and are leaders in both the treatment of cancers and the development of innovative treatment strategies.
The key characteristics of the 13 Clinical Centers at Smilow Cancer Hospital are:
- Patient centered care
- Rapid access to appointments and relevant tests
- Personalized care led by a physician in collaboration with a team of specialists
- Personal communication and assistance from a dedicated intake specialist and nurse coordinator
- Compassion and support for the psychological aspects of cancer
- Rapid communication with and involvement of outside primary care and referring physicians
Ways to stay safe during chemotherapy and immunotherapy.
Latest News
- March 27, 2025
Yale Pathologists Share Insight, Latest Research at USCAP 2025
- March 27, 2025
Prostate and Urologic Cancers Program at Smilow Cancer Hospital at Greenwich
- March 27, 2025Source: Yale News
How Inherited Cancer Risks Can Be Used for Effective Personalized Therapy
- March 27, 2025Source: Yale News
Eight Yale Faculty Members Named AAAS Fellows
- March 26, 2025
A Genetic Screen Identifies a New Master Regulator of Brain Metastasis
- March 26, 2025
Neutrophils in the Immune System Help Build Healthy Skin
- March 26, 2025
Lymphedema Expertise at Smilow Cancer Hospital
- March 26, 2025Source: WTNH News 8 (with Dr. James Hansen)
Yale researchers use lupus antibody to possibly treat glioblastoma
- March 26, 2025
Cancer Physicians, Researchers Urged âTell Our Storiesâ
- March 26, 2025Source: NBC Connecticut (with Dr. Natalia Neparidze)
Yale Cancer Center conducting research about myeloma
- March 25, 2025
Lupus-Related Antibody Shows Promise in Enhancing Cancer Treatment Efficacy
- March 25, 2025
Yale Research Compares Virtual and In-Person Learning Among Medical Students